We are all anxiously waiting for the final version of the new EU GDP Guidelines that are expected for release early 2013. We attended a seminar end of November in Munich to hear the latest news from the Head of our responsible inspection authorities. It looks like there will be several adaptions vs. the initial draft. We have already started to prepare ourselves for the more stringent rules on transport and temperature monitoring during transport by working on new SOP´s.
The shortages for several oncological injectable products continue in Europe, US and several other countries. We do have close cooperation with several reputable Generic Manufacturers and deliver products with full documentation at reasonable prices. Last year we supplied bigger batches of Irinotecan, Paclitaxel, Docetaxel, Doxorubicin and Carboplatin to our customers and helped them to overcome product shortages or potential delays in clinical trials.
Medizone´s partner in Russia recently opened a state-of-the-art, GxP compliant depot for study medications and clinical trial material located near Moscow not far away from Domodedovo airport. Our partner has storage capabilities in all temperature conditions: ambient, chilled, frozen and LN2. The services cover all logistical aspects:
We have performed successfully many local sourcing project for comparators. We can provide CoA´s and batch info prior to purchase.